Incidence, risk factors, management strategies, and outcomes of antibody-mediated rejection in pediatric kidney transplant recipients—a multicenter analysis of the Cooperative European Paediatric Renal Transplant Initiative (CERTAIN)

This study provides an estimate of the incidence of de novo HLA-DSA and ABMR in pKTR and highlights the importance of BKPyV nephropathy as a strong risk factor for allograft dysfunction.

Authors

Institutions

Publication Details

Journal
Pediatric Nephrology
Published
2024-09-16
DOI
https://doi.org/10.1007/s00467-024-06487-2
Citations
10
Primary Topic
Renal Transplantation Outcomes and Treatments
Type
article
Field-Weighted Citation Impact
5.08

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Incidence, risk factors, management strategies, and outcomes of antibody-mediated rejection in pediatric kidney transplant recipients—a multicenter analysis of the Cooperative European Paediatric Renal Transplant Initiative (CERTAIN)

Alexander Fichtner, Licia Peruzzi, Krisztina Rusai, Andrea Carraro et al.
10 citations
Pediatric Nephrology
Renal Transplantation Outcomes and Treatments
5.08
article

Incidence, risk factors, management strategies, and outcomes of antibody-mediated rejection in pediatric kidney transplant recipients—a multicenter analysis of the Cooperative European Paediatric Renal Transplant Initiative (CERTAIN)

Alexander Fichtner, Licia Peruzzi, Krisztina Rusai, Andrea Carraro, Jun Oh, Atif Awan, Nikoleta Printza, Lutz T. Weber, Christian Patry, Laura Gauché, Anja Büscher, Caner Süsal, Kai Krupka, Isabella Guzzo, Marcus Weitz, Jon Jin Kim, Rezan Topaloğlu, Matthias Zirngibl, Britta Höcker, Thuong Hien Tran, László Berta, Lars Pape, Jens König, Thomas Simon, Susanne Rieger, Burkhard Tönshoff, Rüdiger Waldherr, Anette Melk
article en
10 citations

Abstract

This study provides an estimate of the incidence of de novo HLA-DSA and ABMR in pKTR and highlights the importance of BKPyV nephropathy as a strong risk factor for allograft dysfunction.

Pediatric NephrologyVol. 40(2)
Semmelweis University (HU), Koç University (TR), University of Padua (IT), Université Fédérale de Toulouse Midi-Pyrénées (FR), Aristotle University of Thessaloniki (GR), Heidelberg University (DE), University Hospital Heidelberg (DE), Temple Street Children's University Hospital (IE), Medizinische Hochschule Hannover (DE), Comprehensive Cancer Center Vienna (AT), Toulouse Mathematics Institute (FR), University Hospital Münster (DE), Kinderkrebs-Zentrum Hamburg (DE), Essen University Hospital (DE), Bambino Gesù Children's Hospital (IT), University Children's Hospital Tübingen (DE), Ospedale Regina Margherita (IT), University Hospital Cologne (DE), Hacettepe University (TR), Medical University of Vienna (AT), Heidelberg University (US)
Bristol-Myers Squibb, GlaxoSmithKline, Alexion Pharmaceuticals, CSL Behring, European Commission, Astellas Pharma, H2020 European Research Council
Openalex Percentile: Top 4%
Renal Transplantation Outcomes and Treatments
5.08
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.